CTRI/2023/05/052254尚未招募Unknown
GENETIC STUDY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA GENE POLYMORPHISM IN ACUTE CORONARY SYNDROME
BLDE (DEEMED TO BE UNIVERSITY)0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME
排除标准
- •1.PATIENTS WITH VALVULAR HEART DISEASE AND CARDIOMYOPATHY.
- •2.PATIENTS WITH CONGENTIAL HEART DISEASE.
研究者
相似试验
已完成
不适用
Can the use of the Peroxisome Proliferator-Activated Receptor (PPAR)-gamma agonist rosiglitazone reverse the abnormal distribution of fat, as well as disturbances in glucose and lipid metabolism in Human Immunodeficiency Virus (HIV)-associated lipodystrophy syndrome?Human Immunodeficiency Virus (HIV)-associated lipodystrophy syndromeInfections and InfestationsHuman Immunodeficiency VirusISRCTN78808170Academic Medical Centre (AMC) (The Netherlands)15
进行中（未招募）
1 期
The use of Peroxisome Proliferator Activator Receptor Agonists in the management of Androgen Independent Prostate Cancer - PPAREUCTR2006-001398-44-GBBarts and The London NHS Trust49
招募中
2 期
Study of the expression of genes involved in the process of death in oocytes in four groups of patients undergoing ovulation stimulation cycle with four therapies.IRCT20101115005181N16Tehran University of Medical Sciences80
进行中（未招募）
不适用
The effect of peroxisome proliferator activator receptor ? agonist pre-treatment on pegylated interferon-a2a and ribavirin efficacy in hepatitis C patients, previously resistant to treatment with pegylated interferon and ribavirin - a randomized-controlled trial - - HEPAR studyChronic hepatitis C infectionMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2007-007075-16-NLVU university medical center50
撤回
不适用
The effect of peroxisome proliferator activator receptor * agonist pre-treatment on pegylated interferon-*2a and ribavirin efficacy in hepatitis C patients, previously resistant to treatment with pegylated interferon and ribavirin - a randomized-controlled trialViral liver disease1001965410047438Hepatitis CNL-OMON31787Vrije Universiteit Medisch Centrum50